CHM 6.67% 1.6¢ chimeric therapeutics limited

Ann: Successful Completion of First Patient Cohort Phase 1 Trial, page-19

  1. 94 Posts.
    lightbulb Created with Sketch. 80
    Announcement only states that all patients reached 28 days (from date of treatment) without experiencing dose limiting toxicity.

    So no positive status updates (not that we would be expecting them at this stage) on any of the patients unfortunately.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.6¢
Change
0.001(6.67%)
Mkt cap ! $14.29M
Open High Low Value Volume
1.6¢ 1.6¢ 1.6¢ $320 20K

Buyers (Bids)

No. Vol. Price($)
20 2821082 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 794634 4
View Market Depth
Last trade - 10.02am 18/09/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.